Literature DB >> 31983537

Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth.

Maojin Yao1, P Britten Ventura1, Ying Jiang1, Fausto J Rodriguez2, Lixin Wang3, Justin S A Perry1, Yibo Yang1, Kelsey Wahl4, Rowena B Crittenden5, Mariko L Bennett6, Lin Qi7, Cong-Cong Gong8, Xiao-Nan Li7, Ben A Barres6, Timothy P Bender5, Kodi S Ravichandran9, Kevin A Janes3, Charles G Eberhart2, Hui Zong10.   

Abstract

The tumor microenvironment (TME) is critical for tumor progression. However, the establishment and function of the TME remain obscure because of its complex cellular composition. Using a mouse genetic system called mosaic analysis with double markers (MADMs), we delineated TME evolution at single-cell resolution in sonic hedgehog (SHH)-activated medulloblastomas that originate from unipotent granule neuron progenitors in the brain. First, we found that astrocytes within the TME (TuAstrocytes) were trans-differentiated from tumor granule neuron precursors (GNPs), which normally never differentiate into astrocytes. Second, we identified that TME-derived IGF1 promotes tumor progression. Third, we uncovered that insulin-like growth factor 1 (IGF1) is produced by tumor-associated microglia in response to interleukin-4 (IL-4) stimulation. Finally, we found that IL-4 is secreted by TuAstrocytes. Collectively, our studies reveal an evolutionary process that produces a multi-lateral network within the TME of medulloblastoma: a fraction of tumor cells trans-differentiate into TuAstrocytes, which, in turn, produce IL-4 that stimulates microglia to produce IGF1 to promote tumor progression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TME; astrocytes; brain tumor; cellular network; medulloblastoma; microglia; paracrine signaling; trans-differentiation; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 31983537      PMCID: PMC7259679          DOI: 10.1016/j.cell.2019.12.024

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  130 in total

1.  Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter.

Authors:  M Mohrs; K Shinkai; K Mohrs; R M Locksley
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

2.  Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development.

Authors:  Ilia D Vainchtein; Gregory Chin; Frances S Cho; Kevin W Kelley; John G Miller; Elliott C Chien; Shane A Liddelow; Phi T Nguyen; Hiromi Nakao-Inoue; Leah C Dorman; Omar Akil; Satoru Joshita; Ben A Barres; Jeanne T Paz; Ari B Molofsky; Anna V Molofsky
Journal:  Science       Date:  2018-02-01       Impact factor: 47.728

3.  Identifying single-cell molecular programs by stochastic profiling.

Authors:  Kevin A Janes; Chun-Chao Wang; Karin J Holmberg; Kristin Cabral; Joan S Brugge
Journal:  Nat Methods       Date:  2010-03-14       Impact factor: 28.547

4.  Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.

Authors:  Zeng-Jie Yang; Tammy Ellis; Shirley L Markant; Tracy-Ann Read; Jessica D Kessler; Melissa Bourboulas; Ulrich Schüller; Robert Machold; Gord Fishell; David H Rowitch; Brandon J Wainwright; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2008-08-12       Impact factor: 31.743

5.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Authors:  Lin Deng; Jin-Feng Zhou; Rani S Sellers; Jiu-Feng Li; Andrew V Nguyen; Yubao Wang; Amos Orlofsky; Qiang Liu; David A Hume; Jeffrey W Pollard; Leonard Augenlicht; Elaine Y Lin
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

6.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Authors:  Ainhoa Arina; Christian Idel; Elizabeth M Hyjek; Maria-Luisa Alegre; Ying Wang; Vytautas P Bindokas; Ralph R Weichselbaum; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-17       Impact factor: 11.205

7.  The monocyte/macrophage infiltrate in 35 medulloblastomas: a paraffin-wax study.

Authors:  M L Rossi; J R Buller; S A Heath; M P Carey; P Carboni; G Koutsoubelis; H B Coakham
Journal:  Tumori       Date:  1991-02-28

8.  NEUROCYTOMA OR NEUROBLASTOMA, A KIND OF TUMOR NOT GENERALLY RECOGNIZED.

Authors:  J H Wright
Journal:  J Exp Med       Date:  1910-07-23       Impact factor: 14.307

Review 9.  Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.

Authors:  Farzana Ahmed; Nikolas K Haass
Journal:  Front Oncol       Date:  2018-05-24       Impact factor: 6.244

10.  Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor.

Authors:  T Kurihara; G Warr; J Loy; R Bravo
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  38 in total

1.  Astrocytes: new stars in the medulloblastoma firmament.

Authors:  Charles Eberhart
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

2.  Challenges and Recent Advances of Novel Chemical Inhibitors in Medulloblastoma Therapy.

Authors:  Anand Maurya; Upendra Kumar Patel; Jitendra Kumar Yadav; Virender Pratap Singh; Alka Agarwal
Journal:  Methods Mol Biol       Date:  2022

3.  PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma.

Authors:  Jiaqing Yi; BongWoo Kim; Xuanming Shi; Xiaoming Zhan; Q Richard Lu; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Res       Date:  2022-08-16       Impact factor: 13.312

4.  Mosaic Analysis with Double Markers reveals IGF1R function in granule cell progenitors during cerebellar development.

Authors:  Tiffany T Terry; Tao Cheng; Moe Mahjoub; Hui Zong
Journal:  Dev Biol       Date:  2020-07-19       Impact factor: 3.582

5.  An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.

Authors:  Thomas K Albert; Marta Interlandi; Martin Sill; Monika Graf; Natalia Moreno; Kerstin Menck; Astrid Rohlmann; Viktoria Melcher; Sonja Korbanka; Gerd Meyer Zu Hörste; Tobias Lautwein; Michael C Frühwald; Christian F Krebs; Dörthe Holdhof; Melanie Schoof; Annalen Bleckmann; Markus Missler; Martin Dugas; Ulrich Schüller; Natalie Jäger; Stefan M Pfister; Kornelius Kerl
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

6.  Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.

Authors:  Jiaqing Yi; Xuanming Shi; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Lett       Date:  2020-11-27       Impact factor: 8.679

Review 7.  Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment.

Authors:  Yanming Luo; Shuangshuang Yin; Jia Lu; Shiyue Zhou; Yingying Shao; Xiaomei Bao; Tao Wang; Yuling Qiu; Haiyang Yu
Journal:  Cancer Cell Int       Date:  2021-07-20       Impact factor: 5.722

8.  A genome-wide library of MADM mice for single-cell genetic mosaic analysis.

Authors:  Ximena Contreras; Nicole Amberg; Amarbayasgalan Davaatseren; Andi H Hansen; Johanna Sonntag; Lill Andersen; Tina Bernthaler; Carmen Streicher; Anna Heger; Randy L Johnson; Lindsay A Schwarz; Liqun Luo; Thomas Rülicke; Simon Hippenmeyer
Journal:  Cell Rep       Date:  2021-06-22       Impact factor: 9.423

Review 9.  Multifaceted microglia - key players in primary brain tumour heterogeneity.

Authors:  Lily Keane; Mathilde Cheray; Klas Blomgren; Bertrand Joseph
Journal:  Nat Rev Neurol       Date:  2021-03-10       Impact factor: 42.937

10.  Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.

Authors:  Duancheng Guo; Yuan Wang; Yan Cheng; Shengyou Liao; Jian Hu; Fang Du; Gang Xu; Yongqiang Liu; Kathy Q Cai; Martin Cheung; Brandon J Wainwright; Q Richard Lu; Yi Zhao; Zeng-Jie Yang
Journal:  J Exp Med       Date:  2021-07-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.